StockSelector.com
  Research, Select, & Monitor Friday, March 22, 2019 2:46:42 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
ACADIA Pharmaceuticals Inc.$26.17($1.05)(3.86%)

  Quote | Ranking | Chart | Valuations | Sentiment | News | Earnings | Analysts | More...

Your Target?

  ACADIA Pharmaceuticals Inc. vs Biotechnology

Acadia Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. Their three clinical programs are ACP-103 for treatment-induced dysfunction in Parkinson's disease, and ACP-104 and ACP-103, both for the treatment of schizophrenia.




An exciting industry consisting of companies who develop new drugs to combat such diseases as cancer and other life-threatening diseases. Some may also participate in gene therapy. These firms either bring new drugs to the market themselves (which is a grueling process) or they sell their technology to bigger pharmaceutical companies.
 Totals Company Industry
  Sales: $223.8 Mil $96,330.8 Mil
  Market Cap: $3,404.7 Mil $466,832.4 Mil
  Analysts Recommendation: Buy Buy

 Averages Company Industry
 Growth
  Historic Revenue: 79.2% 96.4%
  Estimated Revenue: N/A 17.6%
  Historic Earnings: N/A (8.3%)
  Estimated Earnings: N/A 14.8%
  Stock Price (1 Year): 10.4% 88.4%
  Cash per Share: 92.8% 22.9%
  Dividend: N/A N/A
 Price
  Trailing PE: N/A N/A
  Forward PE: N/A 106.1
  Price-to-Sales: 15.2 N/A
  Price-to-Book: 7.1 5.9
  Dividend Yield: N/A N/A
  Market Cap: $3,404.7 Mil $10,148.5 Mil
  Operations
  Net Margin: (109.6%) (408.9%)
  Gross Margin: 94.5% 71.6%
  Return on Equity: (.5) (.6)
  Return on Assets: (.5) (.2)
  Balance Sheet
  Current Ratio: 8.8 5.5
  Quick Ratio: 8.8 5.1
  Cash Ratio: 7.9 4.0
  Debt-to-Equity: .1 1.3
  Interest Coverage: N/A 1.3
 Technicals
  Relative-Strength Index: 63.7 46.1

 Other companies in Biotechnology Price Market Cap
  Amgen, Inc.  (AMGN) $191.89 $122,276.1 Mil
  Gilead Sciences, Inc.  (GILD) $64.92 $83,981.8 Mil
  Celgene Corp.  (CELG) $89.63 $62,833.3 Mil
  Biogen Inc.  (BIIB) $226.88 $45,711.8 Mil
  Regeneron Pharmaceuticals Inc.  (REGN) $402.59 $43,886.3 Mil






Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.